Dr Esben Strodl is a senior lecturer in the School of Psychology and Counselling at Queensland University of Technology. He is a Fellow of the Australian Psychological Society, a Fellow of the APS College of Health Psychologists and a Fellow of the APS College of Clinical Psychologists. Prior to becoming an academic, Esben worked as clinical health psychologist for Queensland Health for 10 years. Esben has previously served for 4 years as the National Chair of the APS College of Health Psychologists and has been an associate editor for the journals Australian Psychologist and Clinical Psychologist for over 10 years. Esben’s research interests are in the areas of novel clinical interventions for psychopathology and health psychology (i.e. the relationship between psychological factors and physical health). He has over 50 peer reviewed publications in these areas.
Matthew is a clinical psychologist. He gained his PhD at the University of Queensland where he holds an academic position at the School of Medicine. He coordinates the postgraduate mental health programs.
Matthew has published extensively in the area of evidence based treatments. He has a strong track record in conducting clinical treatment trials and has made internationally recognised contributions to psychological treatments for major depressive disorder and novel online treatment delivery modalities. In 2014 Matthew coauthored with Luis Vitetta and Hollie Alford, 'The gastrointestinal tract microbiome, probiotics, and mood' , published in the journal Inflammopharmacology.
Matthew's current active research interests include researching effectiveness and mechanisms of action in integrative medicine approaches to resistant depression that are nonresponsive to best standard treatments.
Matthew also has active e-health projects in child behaviour management and in the assessment and treatment of mental health patients in rural and remote areas in Australia.
Head of Cancer Cell Immortality Laboratory at the University of NSW, Prince of Wales Clinical School
Margot Rothwell is the Executive Director of BioAdvantage Ltd, a boutique consultancy company she founded in 2007 in Sydney. She specialises in assisting healthcare technology companies to build value through new product and service innovation. Margot provides business analysis and commercial strategy services especially to pharmaceutical and biotech companies with emerging pharmaceuticals, related technologies, or mature products; including due diligence to support for in-licensing or out-licensing decisions.
Margot has over 30 years experience in the pharmaceutical and biomedical industries including technical roles as a Hospital Pharmacist, and in the management of pharmaceutical clinical trials and regulatory affairs. She has considerable marketing and business development experience in the pharmaceutical industry and the public sector research and development sector, and more than 15 years consulting experience. Margot’s qualifications include Bachelor of Pharmacy (University of Otago) and Master of Business Administration with Distinction, (Victoria University of Wellington).
BA, BPsych (Hons), MPsych (Clinical), PhD.
Dr Sophie Parham is a clinical psychologist and researcher at Queensland University of Technology. She completed her PhD in collaboration with Wesley Medical Research and UnitingCare Health, investigating methods to improve the management of physical and mental health problems in chronic disease. She has published in the area of health psychology and was awarded the Australian Psychological Society Prize in Psychology and Vice-Chancellor’s Award for Outstanding Research. She currently works as a psychologist in private practice.
17 July 1930 - 11 November 2017